Acute Aortic Syndrome Clinical Trial
— ONSAAOfficial title:
French National Observatory of Aortic Syndromes
| NCT number | NCT01259843 |
| Other study ID # | 07387 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | August 2008 |
| Est. completion date | December 2010 |
| Verified date | August 2019 |
| Source | French Cardiology Society |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The study examined the clinical characteristics and conditions of care for patients with acute aortic syndrome (AAS) that will identify patients at risk for increased morbidity and mortality and provide a basis for the eventual achievement of specific studies on the optimal therapeutic management according to different risk profiles. The aim of the Observatory is to provide a photograph "size" of practices in France at present, both in the larger centers than in smaller and optimize diagnostic and therapeutic currently available by the activation pathways of rational management.
| Status | Completed |
| Enrollment | 280 |
| Est. completion date | December 2010 |
| Est. primary completion date | December 2010 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Male or female age (e) over 18 years old - Patients with a AAS duly authenticated by further tests - Patients who consented to participate in the study Exclusion Criteria: - Refusal of consent for study participation and ancillary studies - AAS occurring in the aftermath of a traumatic thoracic - Diagnosis AAS aside in favor of an alternative diagnosis |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| French Cardiology Society |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Etiology of AAS | Measure the respective contribution of each of the etiologies of AAS (aortic dissection type A aortic dissection type B aortic wall hematoma, penetrating atherosclerotic ulcer, aneurysm of the thoracic aorta complicated). | 1 day | |
| Secondary | Clinical picture | Identify and define the specific clinical picture of each of these new entities recently dismembered as part of AAS. Indeed, if the clinical presentation of classic aortic dissection A and B is well known, that of other entities, individualized recently, remains poorly described. | 1 day | |
| Secondary | Diagnostic tests | Evaluate the performance and the respective roles of the various diagnostic tests including recent acquisitions little or no invasive; Trans thoracic ultrasound, ultrasound and trans esophageal chest scan. | 1 day |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03647566 -
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
|
||
| Recruiting |
NCT05965453 -
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
|
||
| Recruiting |
NCT05339529 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V
|
N/A | |
| Recruiting |
NCT06277895 -
VOCs in Patients With Acute Cardiogenic Chest Pain
|
N/A | |
| Completed |
NCT02273245 -
Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?
|
N/A | |
| Recruiting |
NCT04699279 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Rosuvastatin) I
|
N/A | |
| Completed |
NCT04711889 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II
|
N/A | |
| Enrolling by invitation |
NCT04398992 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
|
||
| Completed |
NCT04751058 -
Genetic Profile in Patients With Aortic Syndrome
|
||
| Completed |
NCT04430400 -
Integrated Diagnostic Algorithm for Acute Aortic Syndromes
|